Want to invest in MARKSANS? Wait as it showed weakness
22 Mar, 20197 min read
MARKSANS delivered massive losses today. On a longer term basis, investors in MARKSANS PHARMA LIMITED made +0.06% per day. Friday's performance of -1.41% was a significant underperformance compared to it's daily average.
Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Symbol
Price
{{retType}}
|
Tr.
{{detail.symbol}}
{{detail.close}}
{{detail.priceChange}}
{{detail.pctChange}}%
{{detail.name}}
{{detail.trend}}
Share with friends 
